Hemant Shah

A Placebo-Controlled Trial of Obeticholic Acid in Primary Biliary Cholangitis

Frederik Nevens, Pietro Andreoné, G. Mazzella et al. · New England Journal of Medicine · 2016 · 1.1K citations · Full text

Medicine, Pharmacology, Pharmacotherapy +16

Factors Associated With Incomplete Colonoscopy: A Population-Based Study

Hemant Shah, Lawrence Paszat, Refik Saskin et al. · Gastroenterology · 2007 · 354 citations · Full text

Medicine, Clinical Sciences, Clinical Epidemiology +9

Toronto HCC risk index: A validated scoring system to predict 10-year risk of HCC in patients with cirrhosis

Suraj Sharma, Matthew Kowgier, Bettina E. Hansen et al. · Journal of Hepatology · 2017 · 213 citations · Full text

Medicine, Internal Medicine, Gastroenterology +12

Benign Tumors of the Tracheobronchial Tree

Hemant Shah, Louise Garbe, Eric S. Nussbaum et al. · CHEST Journal · 1995 · 191 citations

Medicine, Otolaryngology, Surgery +14

Seladelpar (MBX-8025), a selective PPAR-δ agonist, in patients with primary biliary cholangitis with an inadequate response to ursodeoxycholic acid: a double-blind, randomised, placebo-controlled, phase 2, proof-of-concept study

David Jones, Pol Boudes, Mark G. Swain et al. · ˜The œLancet. Gastroenterology & hepatology · 2017 · 186 citations

Medicine, Pharmacology, Pharmacotherapy +12